Upgrade to SI Premium - Free Trial

BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $81 at Citi

October 30, 2024 5:48 AM
Citi analyst David Lebowitz lowered the price target on BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) to $81.00 (from $93.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles